RxDoctor Payments Data
★ My doctorsLook up a doctor →

Lauren Goedtel, PA

Physician Assistant · Royal Oak, MINPI 1104255496

Payments from drug & device makers

$7,485in general payments, 2019–2025

Across 355 payments — averaging $21.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$679
  • Johnson & Johnson$644
  • Genentech USA, Inc.$376
  • Daiichi Sankyo Inc.$343
  • Eisai Inc.$327
  • Merck$286
  • plus $5K from 54 others

What the payments were for

  • Food & beverage$7,40499%
  • Education$811%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis39$679
Johnson & Johnson(2 entities)28$644
Genentech USA, Inc.18$376
Daiichi Sankyo Inc.20$343
Eisai Inc.15$327
Merck12$286
AstraZeneca(2 entities)11$243
Sobi, Inc10$235
Sanofi10$229
Amgen11$223
Astellas Pharma US Inc10$222
Regeneron Healthcare Solutions, Inc.7$210
Ipsen Biopharmaceuticals, Inc8$187
E.r. Squibb & Sons, L.L.C.10$168
AbbVie8$163
Incyte Corporation8$149
GSK8$148
Lilly USA, LLC7$136
EMD Serono, Inc.6$126
Bristol Myers Squibb6$121
Mirati Therapeutics, Inc.6$119
Servier Pharmaceuticals LLC6$119
Legend Biotech USA Inc.3$117
Geron Corporation2$115
Beigene USA, Inc.5$107
Beone Medicines USA, Inc.4$96
Takeda Pharmaceuticals U.S.A., Inc.3$94
Seagen Inc.5$91
Gilead5$87
Pfizer5$84
Pharmacosmos Therapeutics Inc.4$80
Pharmacyclics LLC, An Abbvie Company3$72
Bayer4$71
Kyowa Kirin, Inc.3$66
Tersera Therapeutics LLC3$63
Acrotech Biopharma Inc.3$63
AVEO Pharmaceuticals, Inc.4$60
ADC Therapeutics America, Inc.2$52
Taiho Oncology, Inc.2$51
Iovance Biotherapeutics, Inc.2$50
Deciphera Pharmaceuticals Inc.3$49
Pharmaessentia USA Corporation2$46
Azurity Pharmaceuticals, Inc.2$41
Blueprint Medicines Corporation2$39
Springworks Therapeutics, Inc.1$38
Rigel Pharmaceuticals, Inc.2$35
Jazz Pharmaceuticals Inc.1$33
Agios Pharmaceuticals, Inc.1$30
AMAG Pharmaceuticals, Inc.2$28
Fresenius Kabi USA, LLC1$27
Recordati_rare_diseases_inc.1$27
Caris MPI, Inc.1$26
Alnylam Pharmaceuticals Inc.1$24
Genmab U.S., Inc.1$23
Sun Pharmaceutical Industries Inc.1$21
Puma Biotechnology, Inc.1$21
Boehringer Ingelheim1$20
Exelixis Inc.1$19
Organon1$19
Secura Bio, Inc.1$18

How this compares

$7,485 in reported general payments places this provider in the 95th percentile of 5,453 physician assistant providers in Michigan.

See all physician assistant providers in Michigan →

Medicare billing

Part B allowed, 2024
$12,078
Medicare patients
65
Services billed
664

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other physician assistant in Royal Oak

See the full list for Michigan →

Where these figures come from

Is this you, or does something look wrong? →